<?xml version='1.0' encoding='utf-8'?>
<document id="32237282"><sentence text="Interactions between reinforcement history and drug-primed reinstatement: Studies with MDPV and mixtures of MDPV and caffeine."><entity charOffset="108-112" id="DDI-PubMed.32237282.s1.e0" text="MDPV" /><entity charOffset="117-125" id="DDI-PubMed.32237282.s1.e1" text="caffeine" /><entity charOffset="87-94" id="DDI-PubMed.32237282.s1.e2" text="MDPV" /><pair ddi="false" e1="DDI-PubMed.32237282.s1.e2" e2="DDI-PubMed.32237282.s1.e2" /><pair ddi="false" e1="DDI-PubMed.32237282.s1.e2" e2="DDI-PubMed.32237282.s1.e0" /><pair ddi="false" e1="DDI-PubMed.32237282.s1.e2" e2="DDI-PubMed.32237282.s1.e1" /><pair ddi="false" e1="DDI-PubMed.32237282.s1.e0" e2="DDI-PubMed.32237282.s1.e0" /><pair ddi="false" e1="DDI-PubMed.32237282.s1.e0" e2="DDI-PubMed.32237282.s1.e1" /></sentence><sentence text="Many drugs of abuse are mixed with other psychoactive substances (e" /><sentence text="g" /><sentence text=", caffeine) prior to their sale or use"><entity charOffset="2-10" id="DDI-PubMed.32237282.s4.e0" text="caffeine" /></sentence><sentence text=" Synthetic cathinones (e"><entity charOffset="11-21" id="DDI-PubMed.32237282.s5.e0" text="cathinones" /></sentence><sentence text="g" /><sentence text=", 3,4-methylenedioxypyrovalerone [MDPV]) are commonly mixed with caffeine or other cathinones (e"><entity charOffset="2-32" id="DDI-PubMed.32237282.s7.e0" text="3,4-methylenedioxypyrovalerone" /><entity charOffset="65-73" id="DDI-PubMed.32237282.s7.e1" text="caffeine" /><entity charOffset="83-93" id="DDI-PubMed.32237282.s7.e2" text="cathinones" /><entity charOffset="34-43" id="DDI-PubMed.32237282.s7.e3" text="MDPV" /><pair ddi="false" e1="DDI-PubMed.32237282.s7.e0" e2="DDI-PubMed.32237282.s7.e0" /><pair ddi="false" e1="DDI-PubMed.32237282.s7.e0" e2="DDI-PubMed.32237282.s7.e3" /><pair ddi="false" e1="DDI-PubMed.32237282.s7.e0" e2="DDI-PubMed.32237282.s7.e1" /><pair ddi="false" e1="DDI-PubMed.32237282.s7.e0" e2="DDI-PubMed.32237282.s7.e2" /><pair ddi="false" e1="DDI-PubMed.32237282.s7.e3" e2="DDI-PubMed.32237282.s7.e3" /><pair ddi="false" e1="DDI-PubMed.32237282.s7.e3" e2="DDI-PubMed.32237282.s7.e1" /><pair ddi="false" e1="DDI-PubMed.32237282.s7.e3" e2="DDI-PubMed.32237282.s7.e2" /><pair ddi="false" e1="DDI-PubMed.32237282.s7.e1" e2="DDI-PubMed.32237282.s7.e1" /><pair ddi="false" e1="DDI-PubMed.32237282.s7.e1" e2="DDI-PubMed.32237282.s7.e2" /></sentence><sentence text="g" /><sentence text=", 3,4-methylenedioxy-N-methylcathinone [methylone]), and these &quot;bath salts&quot; mixtures (e" /><sentence text="g" /><sentence text=", MDPV + caffeine) can exhibit supra-additive interactions with regard to their reinforcing and discriminative stimulus properties"><entity charOffset="2-5" id="DDI-PubMed.32237282.s11.e0" text="MDPV" /></sentence><sentence text=" However, little is known about relapse-related effects of drug mixtures" /><sentence text=" In these studies, male Sprague-Dawley rats self-administered 0" /><sentence text="032 mg/kg/inf MDPV or a mixture of MDPV + caffeine (0"><entity charOffset="35-50" id="DDI-PubMed.32237282.s14.e0" text="MDPV + caffeine" /><entity charOffset="14-28" id="DDI-PubMed.32237282.s14.e1" text="MDPV" /><pair ddi="false" e1="DDI-PubMed.32237282.s14.e1" e2="DDI-PubMed.32237282.s14.e1" /><pair ddi="false" e1="DDI-PubMed.32237282.s14.e1" e2="DDI-PubMed.32237282.s14.e0" /></sentence><sentence text="029 + 0" /><sentence text="66 mg/kg/inf, respectively) and then underwent multiple rounds of extinction and reinstatement testing to evaluate the influence of reinforcement history and drug-associated stimuli on the effectiveness of saline (drug-paired stimuli alone), MDPV (0"><entity charOffset="242-245" id="DDI-PubMed.32237282.s16.e0" text="MDPV" /></sentence><sentence text="032-1" /><sentence text="0 mg/kg), caffeine (1"><entity charOffset="10-18" id="DDI-PubMed.32237282.s18.e0" text="caffeine" /></sentence><sentence text="0-32 mg/kg), and mixtures of MDPV:caffeine (in 3:1, 1:1, and 1:3 ratios, relative to each drug's ED50 ) to reinstate responding"><entity charOffset="34-42" id="DDI-PubMed.32237282.s19.e0" text="caffeine" /><entity charOffset="29-36" id="DDI-PubMed.32237282.s19.e1" text="MDPV" /><pair ddi="false" e1="DDI-PubMed.32237282.s19.e1" e2="DDI-PubMed.32237282.s19.e1" /><pair ddi="false" e1="DDI-PubMed.32237282.s19.e1" e2="DDI-PubMed.32237282.s19.e0" /></sentence><sentence text=" Dose-addition analyses were used to determine the nature of the drug-drug interaction for each mixture" /><sentence text=" MDPV and caffeine dose-dependently reinstated responding and were equally effective, regardless of reinforcement history"><entity charOffset="10-18" id="DDI-PubMed.32237282.s21.e0" text="caffeine" /><entity charOffset="1-8" id="DDI-PubMed.32237282.s21.e1" text="MDPV" /><pair ddi="false" e1="DDI-PubMed.32237282.s21.e1" e2="DDI-PubMed.32237282.s21.e1" /><pair ddi="false" e1="DDI-PubMed.32237282.s21.e1" e2="DDI-PubMed.32237282.s21.e0" /></sentence><sentence text=" Most fixed ratio mixtures of MDPV + caffeine exhibited supra-additive interactions, reinstating responding to levels greater than was observed with caffeine and/or MDPV alone"><entity charOffset="149-157" id="DDI-PubMed.32237282.s22.e0" text="caffeine" /><entity charOffset="30-37" id="DDI-PubMed.32237282.s22.e1" text="MDPV" /><entity charOffset="165-172" id="DDI-PubMed.32237282.s22.e2" text="MDPV" /><pair ddi="false" e1="DDI-PubMed.32237282.s22.e1" e2="DDI-PubMed.32237282.s22.e1" /><pair ddi="false" e1="DDI-PubMed.32237282.s22.e1" e2="DDI-PubMed.32237282.s22.e0" /><pair ddi="false" e1="DDI-PubMed.32237282.s22.e1" e2="DDI-PubMed.32237282.s22.e2" /><pair ddi="false" e1="DDI-PubMed.32237282.s22.e0" e2="DDI-PubMed.32237282.s22.e0" /><pair ddi="false" e1="DDI-PubMed.32237282.s22.e0" e2="DDI-PubMed.32237282.s22.e2" /></sentence><sentence text=" Drug-associated stimuli also played a key role in reinstating responding, especially for caffeine"><entity charOffset="90-98" id="DDI-PubMed.32237282.s23.e0" text="caffeine" /></sentence><sentence text=" Together, these results demonstrate that the composition of drug mixtures can impact relapse-related effects of drug mixtures, and &quot;bath salts&quot; mixtures (MDPV + caffeine) may be more effective at promoting relapse-related behaviors than the constituents alone"><entity charOffset="155-162" id="DDI-PubMed.32237282.s24.e0" text="MDPV" /></sentence><sentence text=" Further research is needed to determine how other polysubstance reinforcement histories can impact relapse-related behaviors" /><sentence text="" /></document>